Loading
ASP Isotopes Inc. Stock: price and insider trades · United States
US·Mcap US$328.1M
No insider purchase over the last 90 days. The latest was filed 10 Jul 2024.
ASP Isotopes Inc.: what insiders have been doing
ASP Isotopes Inc. is a listed company. Its directors and officers file their transactions with SEC (Form 4). Between 18 October 2025 and 18 October 2026, 5 insiders published 7 filings.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
Compared with its exchange (5,813 companies, median 19 filings), a count of 7 filings is below the norm. Since 2022, the database holds 1 purchase and 1 sale by insiders of the company.
Over the last twelve months, not one insider purchase of ASP Isotopes Inc. stock was filed. Most trades are made public on the day they happen. Section 16 rules allow two business days to file each Form 4.
For comparison within the same market, see the insider buying recorded at GameStop Corp. and Heico Corp. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Insider Decl.
22
Thresholds
n/a
Buy Volume
€196,991
1 ops. · all time
Sell Volume
€72,312
1 ops. · all time
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 23,710 of 24,148 companies
9.5
score / 100
Value9
Quality10
FCF yld-14%
Earn yld-53%
EV/EBITDA·
ROE-90%
Gross mgn14%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
US$2.14
Analyst consensus
3 analysts1.00/5
US$11.00Target US$13.00(+507%)US$15.00
Income statement
RevenueUS$23.8M
Gross profitUS$3.4M14% margin
EBITDA-US$157.1M-659% margin
Net income-US$175.1M-734.2% margin
Valuation
PER (forward)-2.6x
P/Book1.1x
Beta3.70
Balance sheet & cash
Market capUS$328.1M
Total debtUS$216M
Free Cash Flow-US$47.4M
Debt / Equity98%
Profitability & ownership
ROE-90.3%
ROA-17.0%
% insiders10.5%
% institutions48.1%
Last declaration on 16 October 2026
Declarations22 total
21,830 shares@ US$2.1977Common StockSEC144:0001974494-26-000318
22,500 shares@ US$2.070.015% mcap45.2% of flowCommon StockSEC144:0001477932-26-006223
200,000 shares@ US$2.950.13% mcap48.5% of flowCommonSEC144:0001968582-26-001011
100,000 shares@ US$6.220.14% mcap100.0% of flowCommon StockSEC144:0001477932-26-004135
30,000 shares@ US$6.220.041% mcap100.0% of flowCommon StockSEC144:0001477932-26-004091
100,000 shares@ US$6.280.14% mcap51.5% of flowCommonSEC144:0001968582-26-000666
8,438 shares@ US$6.890.0091% mcap100.0% of flowCOMMON STOCKSEC144:0001477932-26-003698
30,000 shares@ US$3.025623.6% of flowCommon Stock, par value $0.01 per shareSEC:0000902664-24-005853:0
31,849 shares@ US$2.449320.5% of flowCommon Stock, par value $0.01 per share ("Common Stock")SEC:0000902664-24-004969:0
70,000 shares@ US$3.04855.9% of flowCommon Stock, par value $0.01 per share ("Common Stock")SEC:0000902664-24-004664:0
Canonical exit: 6 Oct 2024 (T+90)
93,458 sharesCommon StockSEC:0001477932-24-000883:0
50,251 sharesCommon StockSEC:0001477932-24-000885:0
1,000,000 shares0Common StockSEC:0001477932-23-001110:0
50,000 shares0Common StockSEC:0001477932-23-001111:0
200,000 shares0Common StockSEC:0001213900-22-073095:0
600,000 shares0Common StockSEC:0001213900-22-073086:0
200,000 shares0Common StockSEC:0001213900-22-073093:0
600,000 shares0Common StockSEC:0001213900-22-073098:0
200,000 shares0Common StockSEC:0001213900-22-073089:0
200,000 shares0Common StockSEC:0001213900-22-073100:0
37,500 shares@ US$4.00100.0% of flowCommon StockSEC:0001213900-22-072582:0
1,000,000 shares0Common StockSEC:0001213900-22-072582:1
22 of 22 declarations
About ASP Isotopes Inc.
ASP Isotopes Inc. is a NASDAQ-listed company that specializes in the production and distribution of isotopes for medical and industrial applications. It focuses on innovation in the field of stable and radioactive isotopes.
Recent ranked signals on the same market
Purchases our model currently ranks for the recommendations list.
All recommendations
